Arca
Skip to content
Tools
Tools

IL18R1, IL18RAP: IL18 Receptor

Complex in Homo sapiens that 1 drug acts on.

  • Drugs that act on it: 1
  • Approved: 0
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on IL18R1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 1

Approved0

    Phase 30

      Phase 21

      • Iboctadekin

      Phase 10

        The landscape

        Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
        DrugFurthest stageSponsorModalityActionOpen trials
        IboctadekinPhase 2GSKProtein or peptideAgonistIL18 Receptor agonist6

        Open trials

        The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 6 in all, from ClinicalTrials.gov.
        A Sub Study to Investigate the Safety and Tolerability of Aletekitug in Participants With Moderate To Severe Ulcerative ColitisIboctadekinPhase 1RecruitingGlaxoSmithKlineAug 5, 2026
        A Study to Investigate the Safety and Tolerability of Multiple Study Interventions in Participants With Moderate to Severe Ulcerative ColitisIboctadekinPhase 1RecruitingGlaxoSmithKlineAug 5, 2026
        DETERMINATION OF THE EFFECTS OF STAINLESS STEEL CROWNS CEMENTED WITH RESIN CEMENTS ON INTERLEUKIN-10, 12, 18 LEVELS IN GINGIVAL CREVICULAR FLUIDIboctadekinNot applicableNot yet recruitingAfyonkarahisar Health Sciences UniversityFeb 19, 2026
        Pro- and Anti-inflammatory Cytokines in PCOSIboctadekin—RecruitingJagiellonian UniversityJan 27, 2025
        Tadekinig Alfa (IL-18BP) Rescue Therapy for CAR T Cell Related Cytokine Release Syndrome (CRS) and HLH-like SyndromeIboctadekinEarly phase 1RecruitingUniversity of PennsylvaniaMar 31, 2022
        Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067IboctadekinPhase 1 / Phase 2RecruitingSimcha IL-18, Inc.Mar 8, 2021

        Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4804253, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

        Esc

        Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

        Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.